semaglutide plus tirzepatide vs Tirzepatide, which is better for you? GLP-1 therapies such as semaglutide

GIP action in the cardiovascular system The development of the GLP-1RGIPR co-agonist tirzepatide for type 2 diabetes has sparked resurgent interest in the cardiovascular actions of GIP

Common themes in anecdotal patient reports include: Emotional blunting : Some users describe feeling less emotionally reactive or experiencing a 'flattening' of mood, though this is not the same as clinical depression Reduced pleasure from food : Changes in how individuals experience food satisfaction may occur Altered social engagement : As eating patterns change, some individuals report feeling less inclined to participate in social events involving food Anxiety or low mood : A subset of patients report increased anxiety or depressive symptoms, though causality remains unclear It is worth noting that weight loss itself can profoundly affect psychological wellbeing, both positively and negatively

GLP-1 receptor agonists have a plausible mechanism for pancreatic involvement they directly stimulate GLP-1 receptors present in pancreatic tissue

Eli Lilly, the company behind Mounjaro and Zepbound , is leading the development of this new injectable medication

It can also be taken in supplement form